Form 8-K - Current report:
SEC Accession No. 0001641172-25-013021
Filing Date
2025-05-30
Accepted
2025-05-30 16:05:21
Documents
13
Period of Report
2025-05-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41340
  Complete submission text file 0001641172-25-013021.txt   253504

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE biaf-20250527.xsd EX-101.SCH 3786
3 XBRL DEFINITION FILE biaf-20250527_def.xml EX-101.DEF 26628
4 XBRL LABEL FILE biaf-20250527_lab.xml EX-101.LAB 36678
5 XBRL PRESENTATION FILE biaf-20250527_pre.xml EX-101.PRE 25252
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5821
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 251010790
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)